Glenn Cornett, MD, PhD: Chairman, CEO
Biography
Glenn Cornett, MD, PhD, is a highly accomplished professional with a diverse background in the field of healthcare and entrepreneurship. As the Chairman of Navitas Pharma, Cornett successfully founded and led the company in the area of drug repurposing, ultimately achieving a successful exit to Gilead within 3.5 years. Prior to his entrepreneurial ventures, Cornett gained valuable experience working at prestigious organizations such as McKinsey, Eli Lilly, Razorfish, and Los Alamos. Throughout his career, Cornett has been involved in structuring and valuation deals that have driven over $1 billion in value.
Cornett’s educational background is equally impressive, with an MD degree with Distinction in Research from the University of Michigan and a PhD in neuroscience from UCLA. This combination of medical and scientific expertise has enabled him to make significant contributions to the field of neuroscience and pharmaceutical development.
As the CEO of Cogmotos, Cornett has demonstrated his leadership skills and strategic vision in advancing products and driving the company towards liquidity. With his extensive experience in healthcare strategy, marketing, and entrepreneurship, Cornett continues to make a significant impact in the industry.